Cancer Research Meeting Calendar Genetics and Biology of Brain Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Su, J. D.
Right arrow Articles by Durden, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Su, J. D.
Right arrow Articles by Durden, D. L.
[Cancer Research 63, 3585-3592, July 1, 2003]
© 2003 American Association for Cancer Research

Experimental Therapeutics

PTEN and Phosphatidylinositol 3'-Kinase Inhibitors Up-Regulate p53 and Block Tumor-induced Angiogenesis

Evidence for an Effect on the Tumor and Endothelial Compartment1

Jing Dong Su, Lindsey D. Mayo, David B. Donner and Donald L. Durden2

Section of Hematology/Oncology, Department of Pediatrics, Herman B Wells Center for Pediatric Research, Department of Biochemistry and Molecular Biology [J. D. S., D. L. D.], and Department of Microbiology and Immunology [L. D. M., D. B. D.], Walther Oncology Center, Indiana University School of Medicine, Indianapolis, Indiana 46204

Previous work from our laboratory demonstrated that PTEN regulates tumor-induced angiogenesis and thrombospondin 1 expression in malignant glioma. Herein, we demonstrated the first evidence that the systemic administration of a phosphatidylinositol 3'-kinase (PI3K) inhibitor (LY294002) has antitumor and antiangiogenic activity in vivo. We show that PTEN reconstitution diminished phosphorylation of AKT, induced the transactivation of p53 (7.5-fold induction) and increased the expression of p53 target genes, p21waf-1 and insulin-like growth factor binding protein 3 in glioma cells. PTEN and LY294002 induced p53 activity in human brain endothelial cells, suggesting that PTEN and PI3K pathways can suppress the progression of cancer through direct actions on tumor and endothelial cells. The capacity of PTEN and LY294002 to inhibit U87MG or U373MG glioma growth was tested in an ectopic skin and orthotopic brain tumor model. LY294002 inhibited glioma tumor growth in vivo, induced tumor regression, decreased the incidence of brain tumors, and blocked the tumor-induced angiogenic response of U87MG cells in vivo. These data provide evidence that both PTEN and PI3K inhibitors regulate p53 function and display in vivo antiangiogenic and antitumor activity. These results provide evidence that the two tumor suppressor genes, PTEN and p53, act together to block tumor progression in vivo. Our data provide the first preclinical evidence for the in vivo efficacy for LY294002 in the treatment of malignant gliomas.




This article has been cited by other articles:


Home page
 Molecular Cancer TherapeuticsHome page
T.-J. Liu, D. Koul, T. LaFortune, N. Tiao, R. J. Shen, S.-M. Maira, C. Garcia-Echevrria, and W.K. A. Yung
NVP-BEZ235, a novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor, elicits multifaceted antitumor activities in human gliomas
Mol. Cancer Ther., August 1, 2009; 8(8): 2204 - 2210.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
F. Morello, A. Perino, and E. Hirsch
Phosphoinositide 3-kinase signalling in the vascular system
Cardiovasc Res, May 1, 2009; 82(2): 261 - 271.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
W.-Z. Ying, K. Aaron, and P. W. Sanders
Dietary Salt Activates an Endothelial Proline-Rich Tyrosine Kinase 2/c-Src/Phosphatidylinositol 3-Kinase Complex to Promote Endothelial Nitric Oxide Synthase Phosphorylation
Hypertension, December 1, 2008; 52(6): 1134 - 1141.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
I. Bentov, G. Narla, H. Schayek, K. Akita, S. R. Plymate, D. LeRoith, S. L. Friedman, and H. Werner
Insulin-Like Growth Factor-I Regulates Kruppel-Like Factor-6 Gene Expression in a p53-Dependent Manner
Endocrinology, April 1, 2008; 149(4): 1890 - 1897.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. R. Garlich, P. De, N. Dey, J. D. Su, X. Peng, A. Miller, R. Murali, Y. Lu, G. B. Mills, V. Kundra, et al.
A Vascular Targeted Pan Phosphoinositide 3-Kinase Inhibitor Prodrug, SF1126, with Antitumor and Antiangiogenic Activity
Cancer Res., January 1, 2008; 68(1): 206 - 215.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
F. Furuya, C. Lu, M. C. Willingham, and S.-y. Cheng
Inhibition of phosphatidylinositol 3-kinase delays tumor progression and blocks metastatic spread in a mouse model of thyroid cancer
Carcinogenesis, December 1, 2007; 28(12): 2451 - 2458.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. Albini, D. M. Noonan, and N. Ferrari
Molecular Pathways for Cancer Angioprevention
Clin. Cancer Res., August 1, 2007; 13(15): 4320 - 4325.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
G. Potikyan, R. O.V. Savene, J. M. Gaulden, K. A. France, Z. Zhou, E. S. Kleinerman, S. L. Lessnick, and C. T. Denny
EWS/FLI1 Regulates Tumor Angiogenesis in Ewing's Sarcoma via Suppression of Thrombospondins
Cancer Res., July 15, 2007; 67(14): 6675 - 6684.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
N. K. Saxena, D. Sharma, X. Ding, S. Lin, F. Marra, D. Merlin, and F. A. Anania
Concomitant Activation of the JAK/STAT, PI3K/AKT, and ERK Signaling Is Involved in Leptin-Mediated Promotion of Invasion and Migration of Hepatocellular Carcinoma Cells
Cancer Res., March 15, 2007; 67(6): 2497 - 2507.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
R. Dell'Eva, C. Ambrosini, S. Minghelli, D. M. Noonan, A. Albini, and N. Ferrari
The Akt inhibitor deguelin, is an angiopreventive agent also acting on the NF-{kappa}B pathway
Carcinogenesis, February 1, 2007; 28(2): 404 - 413.
[Abstract] [Full Text] [PDF]

Home page
 Jpn J Clin OncolHome page
K. Suphapeetiporn, P. Kongkam, J. Tantivatana, T. Sinthuwiwat, S. Tongkobpetch, and V. Shotelersuk
PTEN c.511C>T Nonsense Mutation in a BRRS Family Disrupts a Potential Exonic Splicing Enhancer and Causes Exon Skipping
Jpn. J. Clin. Oncol., December 1, 2006; 36(12): 814 - 821.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
D Sharma, N K Saxena, P M Vertino, and F A Anania
Leptin promotes the proliferative response and invasiveness in human endometrial cancer cells by activating multiple signal-transduction pathways.
Endocr. Relat. Cancer, June 1, 2006; 13(2): 629 - 640.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
S.-i. Yaguchi, Y. Fukui, I. Koshimizu, H. Yoshimi, T. Matsuno, H. Gouda, S. Hirono, K. Yamazaki, and T. Yamori
Antitumor activity of ZSTK474, a new phosphatidylinositol 3-kinase inhibitor.
J Natl Cancer Inst, April 19, 2006; 98(8): 545 - 556.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Y. Tang and C. Eng
PTEN Autoregulates Its Expression by Stabilization of p53 in a Phosphatase-Independent Manner
Cancer Res., January 15, 2006; 66(2): 736 - 742.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
R. Parsons
Phosphatidylinositol 3-Kinase Inhibitors Are a Triple Threat to Ovarian Cancer
Clin. Cancer Res., November 15, 2005; 11(22): 7965 - 7966.
[Full Text] [PDF]

Home page
 Genes Dev.Home page
K. Hamada, T. Sasaki, P. A. Koni, M. Natsui, H. Kishimoto, J. Sasaki, N. Yajima, Y. Horie, G. Hasegawa, M. Naito, et al.
The PTEN/PI3K pathway governs normal vascular development and tumor angiogenesis
Genes & Dev., September 1, 2005; 19(17): 2054 - 2065.
[Abstract] [Full Text] [PDF]

Home page
 J. Med. Genet.Home page
M M Turnbull, V Humeniuk, B Stein, and G K Suthers
Arteriovenous malformations in Cowden syndrome
J. Med. Genet., August 1, 2005; 42(8): e50 - e50.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
G. Tell, A. Pines, F. Arturi, L. Cesaratto, E. Adamson, C. Puppin, I. Presta, D. Russo, S. Filetti, and G. Damante
Control of Phosphatase and Tensin Homolog (PTEN) Gene Expression in Normal and Neoplastic Thyroid Cells
Endocrinology, October 1, 2004; 145(10): 4660 - 4666.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
N. T. Ihle, R. Williams, S. Chow, W. Chew, M. I. Berggren, G. Paine-Murrieta, D. J. Minion, R. J. Halter, P. Wipf, R. Abraham, et al.
Molecular pharmacology and antitumor activity of PX-866, a novel inhibitor of phosphoinositide-3-kinase signaling
Mol. Cancer Ther., July 1, 2004; 3(7): 763 - 772.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.